论文部分内容阅读
目的:探讨分析罗哌卡因用于分娩镇痛对产程和母婴的影响。方法:抽取在2010年1月至2013年12月间我院收治的120例足月孕妇作为研究对象,其中有60例孕妇采用罗哌卡因进行分娩镇痛,设为研究组,另60例孕妇未采用任何镇痛措施,设为对照组,比较两组患者的产程、新生儿Apgar评分情况以及产后两小时孕妇的出血量,进行回顾性对比分析结果:研究组分娩活跃期和第二产程时间短于对照组,差异均具有统计学意义(p<0.05)。研究组患者在产后2小时多的出血量少于对照组,新生儿Apgar评分优于对照组,但差异不具有统计学意义(p>0.05)。结论:采用罗哌卡因临床麻醉对于分娩镇痛有显著的效果,能明显的缩短孕妇产程,但是在使用过程中要根据产妇实际情况进行正确的用药。
Objective: To investigate the impact of ropivacaine on labor process and maternal-infant analgesia during labor. Methods: A total of 120 full-term pregnant women admitted to our hospital from January 2010 to December 2013 were selected as the study subjects. 60 pregnant women were given analgesia with ropivacaine and were assigned to study group. Another 60 patients Pregnant women did not use any analgesic measures, as the control group, compared the two groups of patients with labor, neonatal Apgar score and postpartum two hours of pregnant women, the amount of bleeding, retrospective comparative analysis of results: study group active labor and second stage labor The time was shorter than the control group, the differences were statistically significant (p <0.05). The patients in the study group had more bleeding at 2 hours postpartum than those in the control group. The Apgar score in neonates was better than that in the control group, but the difference was not statistically significant (p> 0.05). Conclusion: The clinical anesthesia with ropivacaine has a significant effect on labor analgesia, which can obviously shorten the birth process in pregnant women, but the correct medication should be based on the actual situation of the mother during the use.